NLRP3 and hepatocellular carcinoma: A previous study showed that miR-223 inhibited hep3B (hepatocellular carcinoma cell line) cell proliferation and promoted apoptosis by directly targeting NLRP3 (NOD-like receptor family, pyrin domain containing 3) (Wan et al. 2018).